CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +13,488 | 13,488 | ||
| 2024-08-15 | McManus Matthew President - DGS | Grant or award · Performance Restricted Stock Units | +15,818 | 15,818 | ||
| 2024-08-15 | McManus Matthew President - DGS | Grant or award · Restricted Stock Units | +7,912 | 7,912 | ||
| 2024-08-15 | McManus Matthew President - DGS | Grant or award · Stock Option (Right to Buy) | +21,320 | 21,320 | ||
| 2024-08-08 | BAUMGARTNER ROBERT V Director | Option exercise | +16,000 | $22.95 | $367K | 59,401 |
| 2024-08-08 | BAUMGARTNER ROBERT V Director | Sale | −16,000 | $72.10 | $1.2M | 43,401 |
| 2024-08-08 | BAUMGARTNER ROBERT V Director | Option exercise · Stock Options (Right to Buy) | −16,000 | 0 | ||
| 2024-08-02 | Hippel James CFO | Option exercise | +53,000 | $31.26 | $1.7M | 136,002 |
| 2024-08-02 | Hippel James CFO | Shares withheld for taxes | −36,076 | $82.35 | $3.0M | 99,926 |
| 2024-08-02 | Hippel James CFO | Option exercise · Stock Options (Right to Buy) | −53,000 | 53,867 | ||
| 2024-07-31 | Kelderman Kim Chief Executive Officer | Option exercise | +14,000 | $37.70 | $528K | 49,421 |
| 2024-07-31 | Kelderman Kim Chief Executive Officer | Shares withheld for taxes | −9,479 | $81.97 | $777K | 39,942 |
| 2024-07-31 | Kelderman Kim Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −14,000 | 13,392 | ||
| 2024-07-23 | Hippel James CFO | Option exercise | +35,000 | $31.26 | $1.1M | 107,284 |
| 2024-07-23 | Hippel James CFO | Shares withheld for taxes | −24,282 | $77.77 | $1.9M | 83,002 |
| 2024-07-23 | Hippel James CFO | Option exercise · Stock Options (Right to Buy) | −35,000 | 106,867 | ||
| 2024-07-08 | HIGGINS JOHN L Director | Option exercise | +6,000 | $22.95 | $138K | 42,608 |
| 2024-07-08 | HIGGINS JOHN L Director | Option exercise · Stock Options (Right to Buy) | −6,000 | 6,000 | ||
| 2024-05-14 | HIGGINS JOHN L Director | Option exercise | +4,000 | $22.95 | $92K | 40,608 |
| 2024-05-14 | HIGGINS JOHN L Director | Sale | −4,000 | $83.84 | $335K | 36,608 |
Page 16 of 32 · 626 trades